logo
episode-header-image
Feb 2022
39m 49s

Money Talks: The next financial crisis

The Economist
About this episode

Over the past 15 years power and risk in financial markets have shifted radically. New investors have flooded in and, buoyed by pandemic stimulus, most have had an incredible ride. But as policymakers put the brakes on, global financial markets are starting to wobble. How might this new high-tech, bank-light system fare under a serious stress test?


Mike Bird hosts with Alice Fulwood, The Economist’s US finance correspondent; Greg Jensen, co-chief investment officer of Bridgewater Associates; Robert Shiller, professor of economics at Yale University and author of “Narrative Economics”; and The Economist’s Buttonwood columnist, John O’Sullivan.


Sign up for our new weekly newsletter dissecting the big themes in markets, business and the economy at economist.com/moneytalks 

For full access to print, digital and audio editions, subscribe to The Economist at www.economist.com/podcastoffer



Hosted on Acast. See acast.com/privacy for more information.

Up next
May 2025
Trailer: Boss Class Season 2
<p>Good bosses are rare. They don’t have to be. The skills of management can be learned.</p><br><p><em>The Economist</em>’s management columnist, Andrew Palmer, is here to help. The second season of Boss Class features leaders at some of the world’s best performing companies, fro ... Show More
2m 3s
Apr 2025
Import-extort: what to make of Donald Trump’s titanic tariffs
<p>After months of bluster, he’s finally done it. At a ceremony in the White House Rose Garden, Donald Trump overturned decades of American trade policy with a simple signature. The new wave of <a href="https://www.economist.com/finance-and-economics/2025/04/03/trump-takes-americ ... Show More
46m 35s
Jan 2025
Trailer: Scam Inc
<p>A sophisticated, predatory, multi-billion dollar industry is emerging from the shadows. It already rivals the size of the illicit drug trade. And it’s about to get bigger and much more powerful.&nbsp;</p><br><p><em>The Economist</em>’s Sue-Lin Wong follows a trail that starts ... Show More
3m 47s
Recommended Episodes
Feb 2022
Money Talks: The next financial crisis
Over the past 15 years power and risk in financial markets have shifted radically. New investors have flooded in and, buoyed by pandemic stimulus, most have had an incredible ride. But as policymakers put the brakes on, global financial markets are starting to wobble. How might t ... Show More
39m 49s
Dec 2021
Money Talks: Omicronomics
China’s economy is slowing while America’s overheats, prompting Jerome Powell to suggest this week that the Fed could act faster than planned. As the Omicron variant triggers a fresh wave of travel restrictions, is the world economy caught between a rock and a hard place? Host Pa ... Show More
31m 3s
Sep 2022
Inflation, recession? What next for the global economy? Three experts dig into the latest Chief Economists Outlook
<div class= "c-message_kit__blocks c-message_kit__blocks--rich_text"> <div class= "c-message__message_blocks c-message__message_blocks--rich_text" data-qa="message-text"> <div class="p-block_kit_renderer" data-qa="block-kit-renderer"> <div class= "p-block_kit_renderer__block_wrap ... Show More
35m 20s
Aug 2023
In search of a new economic playbook
<p>Chinese corporate earnings reports are forecast to log poor performance and companies are set to downgrade outlooks, and policy makers walked away from Jackson Hole acknowledging they need to adjust to the changing global economy. Plus, the FT’s Jamie Smyth explains why Irelan ... Show More
10m 13s
Dec 2023
Fed Starts to Confront the Next Big Question
Bloomberg News Economics Reporter Rich Miller and Bloomberg Intelligence Chief US Interest Rate Strategist Ira Jersey talk about how the most important question facing the economy and financial markets next year is not whether the Federal Reserve will cut interest rates. It’s why ... Show More
51m 40s
Apr 2024
Money Talks: Why weight-loss drugs will reshape the world
More than 1bn people around the world are obese. That means there should be extraordinary demand for drugs to cure or mitigate the condition. Novo Nordisk is now Europe’s most valuable company and Eli Lilly’s market value has more than doubled. Both make the “miracle” drugs that ... Show More
36m 59s